TY - JOUR
T1 - Adapting to Adulthood
T2 - A Review of Transition Strategies for Osteogenesis Imperfecta
AU - Celli, Luca
AU - Garrelfs, Mark R.
AU - Sakkers, Ralph J.B.
AU - Elting, Mariet W.
AU - Celli, Mauro
AU - Bökenkamp, Arend
AU - Smits, Cas
AU - Goderie, Thadé
AU - Smit, Jan Maerten
AU - Schwarte, Lothar A.
AU - Schober, Patrick R.
AU - Lubbers, Wouter D.
AU - Visser, Marieke C.
AU - Kievit, Arthur J.
AU - van Royen, Barend J.
AU - Gilijamse, Marjolijn
AU - Schreuder, Willem H.
AU - Rustemeyer, Thomas
AU - Pramana, Angela
AU - Hendrickx, Jan Jaap
AU - Dahele, Max R.
AU - Saeed, Peerooz
AU - Moll, Annette C.
AU - Curro–Tafili, Katie R.
AU - Ghyczy, Ebba A.E.
AU - Dickhoff, Chris
AU - de Leeuw, Robert A.
AU - Bonjer, Jaap H.
AU - Nieuwenhuijzen, Jakko A.
AU - Konings, Thelma C.
AU - Engelsman, Anton F.
AU - Eeckhout, Augustinus M.
AU - van den Aardweg, Joost G.
AU - Thoral, Patrick J.
AU - Noske, David P.
AU - Dubois, Leander
AU - Teunissen, Berend P.
AU - Semler, Oliver
AU - Wekre, Lena Lande
AU - Maasalu, Katre
AU - Märtson, Aare
AU - Sangiorgi, Luca
AU - Versacci, Paolo
AU - Riminucci, Mara
AU - Grammatico, Paola
AU - Zambrano, Anna
AU - Martini, Lorena
AU - Castori, Marco
AU - Botman, Esmee
AU - Westerheim, Ingunn
AU - Zhytnik, Lidiia
AU - Micha, Dimitra
AU - Eekhoff, Elisabeth Marelise W.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Osteogenesis Imperfecta (OI), known as “brittle bone disease,” presents a rare genetic disorder characterized by bone fragility, often accompanied by skeletal deformities and extraskeletal complications. OI is primarily associated with collagen type I defects, responsible for the syndromic nature of the disease affecting a broad range of tissues. As such, its multisystemic complexity necessitates multidisciplinary care approaches in all patient life stages. OI treatment remains largely supportive, commonly including bisphosphonates and orthopedic surgeries, which show promise in children. Although rehabilitation programs for children exist, guidelines for adult care and especially the transition from pediatric to adult care, are lagging behind in OI care and research. The current systematic review summarizes the literature on OI patient pediatric to adult care transition experiences and compares OI transition approaches to other chronic diseases. The review was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Systematic searches were conducted across multiple databases. Search terms encompassed synonyms and closely related phrases relevant to “OI” and “Transition to adult care”. The initial screening involved the evaluation of article titles, followed by a thorough review of abstracts to assess relevance for the purpose of the current review. Programs aimed at easing the transition from pediatric to adult OI care necessitate a multifaceted approach. Collaborative efforts between different medical disciplines including pediatricians, endocrinologists, orthopedics, cardiology, pulmonology, ophthalmology, otolaryngologists, maxillofacial specialists, psychologists and medical genetics, are crucial for addressing the diverse needs of OI patients during this critical life phase. Comprehensive education, readiness assessments, personalized transition plans, and further follow-up are essential components of a structured transition framework. Further research is warranted to evaluate the feasibility and efficacy of sequential stepwise transition systems tailored to individuals with OI.
AB - Osteogenesis Imperfecta (OI), known as “brittle bone disease,” presents a rare genetic disorder characterized by bone fragility, often accompanied by skeletal deformities and extraskeletal complications. OI is primarily associated with collagen type I defects, responsible for the syndromic nature of the disease affecting a broad range of tissues. As such, its multisystemic complexity necessitates multidisciplinary care approaches in all patient life stages. OI treatment remains largely supportive, commonly including bisphosphonates and orthopedic surgeries, which show promise in children. Although rehabilitation programs for children exist, guidelines for adult care and especially the transition from pediatric to adult care, are lagging behind in OI care and research. The current systematic review summarizes the literature on OI patient pediatric to adult care transition experiences and compares OI transition approaches to other chronic diseases. The review was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Systematic searches were conducted across multiple databases. Search terms encompassed synonyms and closely related phrases relevant to “OI” and “Transition to adult care”. The initial screening involved the evaluation of article titles, followed by a thorough review of abstracts to assess relevance for the purpose of the current review. Programs aimed at easing the transition from pediatric to adult OI care necessitate a multifaceted approach. Collaborative efforts between different medical disciplines including pediatricians, endocrinologists, orthopedics, cardiology, pulmonology, ophthalmology, otolaryngologists, maxillofacial specialists, psychologists and medical genetics, are crucial for addressing the diverse needs of OI patients during this critical life phase. Comprehensive education, readiness assessments, personalized transition plans, and further follow-up are essential components of a structured transition framework. Further research is warranted to evaluate the feasibility and efficacy of sequential stepwise transition systems tailored to individuals with OI.
KW - Adult care
KW - Continuity of patient care
KW - Multidisciplinary care
KW - Osteogenesis imperfecta
KW - Transitional care
UR - http://www.scopus.com/inward/record.url?scp=85208939524&partnerID=8YFLogxK
U2 - 10.1007/s00223-024-01305-1
DO - 10.1007/s00223-024-01305-1
M3 - Review article
C2 - 39535563
AN - SCOPUS:85208939524
SN - 0171-967X
VL - 115
SP - 960
EP - 975
JO - Calcified Tissue International
JF - Calcified Tissue International
IS - 6
ER -